epi-beta-Santalene is a sesquiterpene hydrocarbon reported as a minor constituent in essential-oil GC-MS profiles.
Aroma and practical use
No aroma description is attached to this identity yet.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
There are no constituent-specific outcome findings in this report. No therapeutic benefit is inferred from its presence.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- Minor GC-MS constituent added during composition completion; profile/SEO detail pending.
- 2026-07-13 third verification pass (audit correction): the prior pass's claim that no CAS/PubChem CID could be resolved was wrong. CAS 25532-78-9 and PubChem CID 11106484 ("Epi-beta-Santalene", C15H24) are real and cross-indexed by PubChem and The Good Scents Company (https://www.thegoodscentscompany.com/data/rw1124001.html, which lists CAS 25532-78-9 and links directly to PubChem CID 11106484). `cas` corrected from null to 25532-78-9 accordingly. However, checking that real CAS/CID against actual safety sources still finds no numeric dermal limit: The Good Scents Company's Safety Information section for this CAS explicitly states 'GHS Classification ... None found', 'Hazard statement(s) ... None found', 'Precautionary statement(s) ... None found', and Oral/Dermal/Inhalation Toxicity 'Not determined'; its Safety in Use section states the material is 'not for fragrance use' / 'not for flavor use' (i.e., no supplier-published usage level exists). No IFRA Standard or RIFM fragrancematerialsafetyresource.elsevier.com assessment for CAS 25532-78-9 was found (queried by CAS), and ECHA C&L Inventory has no entry for this CAS. Santalene hydrocarbons (this constituent) are chemically distinct from the santalol alcohols that carry sandalwood sensitization data, so sensitization data from santalol siblings is not genuinely transferable. dermal_limit_pct, dermal_limit_source, sensitizing therefore remain null rather than guessed; phototoxic remains false consistent with the absence of any hazard classification for this hydrocarbon.
- No constituent-specific outcome findings are available in this report.
- No cited aroma description is available for this identity.
- No public source links are attached to this constituent report.
- No constituent-specific numeric dermal reference is available here.